Filing Details
- Accession Number:
- 0001209191-17-046041
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-24 06:19:59
- Reporting Period:
- 2017-07-20
- Filing Date:
- 2017-07-24
- Accepted Time:
- 2017-07-24 06:19:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1042074 | Cymabay Therapeutics Inc. | CBAY | Pharmaceutical Preparations (2834) | 943103561 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1588862 | Charles Mcwherter | C/O Cymabay Therapeutics, Inc. 7999 Gateway Boulevard, Suite 130 Newark CA 94560 | Svp & Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-07-20 | 100 | $7.42 | 5,100 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-20 | 3,000 | $7.43 | 8,100 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-20 | 200 | $7.43 | 8,300 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-07-20 | 1,700 | $7.43 | 10,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |